EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen
12/23/2025 07:00 AM • EUDA Health Holdings announced a major expansion of its longevity and regenerative medicine strategy by launching a comprehensive stem cell therapy platform and establishing its first clinic in Shenzhen, China. The company is upgrading Shenzhen Inno's cGMP facility to incorporate iPSC technology from GO POSB and Japanese partners, while opening a new longevity clinic offering stem cell therapies, AI-guided life cycle management, and integrated Eastern and Western medicine.
EUDA - Company announced significant strategic expansion with new clinic launch, upgraded production facility, and integration of advanced stem cell technologies. CEO commentary emphasizes this as a 'defining moment' and positions the company to capitalize on the fast-growing longevity sector, indicating strong growth prospects and market positioning.
Investing.com • Thomas Hughes